E. Lapteva

Systemic manifestations in different stages of chronic obstructive pulmonary disease

E. Lapteva, Лаптева Елена Анатольевна, I. Lapteva, 2013 .

Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19

J. Vestbo, A. Mathioudakis, E. Lapteva, 2021, European Respiratory Journal.

Structural and functional features of the colon in patients with non-alcoholic fatty liver disease and comorbid pathology

E. Lapteva, A. Bykova, 2022, Experimental and Clinical Gastroenterology.

Differential Treatment Strategy in Patients with Different Clinical Phenotypes of Chronic Obstructive Pulmonary Disease

E. Lapteva, 2013 .

ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

Alexander G. Mathioudakis, C. Jenkins, B. Beghé, 2021, European Respiratory Journal.

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

C. Jenkins, B. Beghé, P. Williamson, 2020, ERJ Open Research.

APPLICATION OF THE NEURAL NETWORK TECHNOLOGY FOR DETECTION AND MONITORING OF AUSCULTATIVE PHENOMENA IN DIAGNOSIS AND TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM

E. Lapteva, O. Kharevich, A. Pozdnyakova, 2020, Journal of the Grodno State Medical University.

Online Appendix ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease exacerbations

Alexander G. Mathioudakis, B. Beghé, K. Kostikas, 2021 .

Components of the diff use endocrine system of the gastrointestinal tract and nonalcoholic fatty liver disease: interconnections and mutual infl uences

A. Pakhomova, I. Kozlova, E. Lapteva, 2020, Experimental and Clinical Gastroenterology.